Cécile Croix

431 total citations
19 papers, 312 citations indexed

About

Cécile Croix is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Cécile Croix has authored 19 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Cécile Croix's work include Catalytic C–H Functionalization Methods (4 papers), Catalytic Cross-Coupling Reactions (3 papers) and Protein Degradation and Inhibitors (2 papers). Cécile Croix is often cited by papers focused on Catalytic C–H Functionalization Methods (4 papers), Catalytic Cross-Coupling Reactions (3 papers) and Protein Degradation and Inhibitors (2 papers). Cécile Croix collaborates with scholars based in France, Denmark and Poland. Cécile Croix's co-authors include Marie‐Claude Viaud‐Massuard, Alain Duchêne, Gildas Prié, Fabrice Gouilleux, Michel Giorgi, H. Allouchi, Laure Favot, David Alagille, Adriana Delwail and Sylvain Normand and has published in prestigious journals such as Chemical Communications, The Journal of Organic Chemistry and Molecules.

In The Last Decade

Cécile Croix

18 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cécile Croix France 11 145 93 50 35 31 19 312
Mallesh Pandrala United States 11 103 0.7× 116 1.2× 104 2.1× 20 0.6× 23 0.7× 21 299
Ryan A. Davis United States 11 97 0.7× 127 1.4× 97 1.9× 41 1.2× 11 0.4× 34 342
Óscar Gonzalo Spain 7 144 1.0× 201 2.2× 183 3.7× 49 1.4× 20 0.6× 8 421
Paul Rafferty United Kingdom 14 221 1.5× 168 1.8× 70 1.4× 32 0.9× 8 0.3× 21 413
Masood Hosseini Denmark 10 253 1.7× 147 1.6× 54 1.1× 10 0.3× 50 1.6× 14 395
Qingzhou Zhang China 13 184 1.3× 329 3.5× 55 1.1× 11 0.3× 48 1.5× 27 436
Steve Arns Canada 10 251 1.7× 124 1.3× 55 1.1× 7 0.2× 15 0.5× 14 476
Jiyoung A. Hong United States 11 85 0.6× 362 3.9× 35 0.7× 24 0.7× 22 0.7× 16 581
Jens Buchardt Denmark 11 169 1.2× 341 3.7× 72 1.4× 8 0.2× 32 1.0× 19 457
Zhiqiang Ren China 12 47 0.3× 154 1.7× 48 1.0× 41 1.2× 23 0.7× 33 326

Countries citing papers authored by Cécile Croix

Since Specialization
Citations

This map shows the geographic impact of Cécile Croix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Croix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Croix more than expected).

Fields of papers citing papers by Cécile Croix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Croix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Croix. The network helps show where Cécile Croix may publish in the future.

Co-authorship network of co-authors of Cécile Croix

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Croix. A scholar is included among the top collaborators of Cécile Croix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Croix. Cécile Croix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Croix, Cécile, et al.. (2024). Targeted Therapeutic Strategies for the Treatment of Cancer. Cancers. 16(2). 461–461. 33 indexed citations
2.
Croix, Cécile, et al.. (2024). Novel antileukemic compound with sub-micromolar potency against STAT5 addicted myeloid leukemia cells. European Journal of Medicinal Chemistry. 284. 117211–117211.
3.
Aubrey, Nicolas, Valérie Gouilleux‐Gruart, Cécile Croix, et al.. (2022). Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality. Antibodies. 11(3). 54–54. 2 indexed citations
4.
Logé, Cédric, Thomas Robert, Stéphane Bach, et al.. (2021). New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation. Molecules. 26(4). 867–867. 16 indexed citations
5.
Croix, Cécile, et al.. (2020). Uncyclized xanthommatin is a key ommochrome intermediate in invertebrate coloration. Insect Biochemistry and Molecular Biology. 124. 103403–103403. 19 indexed citations
6.
Lahcini, Mohammed, et al.. (2019). Efficient Synthesis of New 2H‐Chromene Retinoids Hybrid Derivatives by Suzuki Cross‐coupling Reactions. Journal of Heterocyclic Chemistry. 56(4). 1260–1274. 2 indexed citations
7.
Croix, Cécile, Stéphane Massip, & Marie‐Claude Viaud‐Massuard. (2018). Synthesis of naphthyridin-2(1H)-one derivativesviaring expansion of 3-substituted-1H-pyrrolo[2,3-b]pyridin-2(3H)-one derivatives. Chemical Communications. 54(44). 5538–5541. 9 indexed citations
8.
Croix, Cécile, Anne‐Sophie Lamort, Sandrine Dallet‐Choisy, et al.. (2017). Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases. Biochemical Pharmacology. 131. 52–67. 38 indexed citations
9.
Croix, Cécile, et al.. (2015). Rhodium-Catalyzed 1,4-Addition of Arylboronic Acids to 3-Benzylidene-1H-pyrrolo[2,3-b]pyridin-2(3H)-one Derivatives. The Journal of Organic Chemistry. 80(6). 3264–3269. 7 indexed citations
10.
Croix, Cécile, et al.. (2012). Efficient and General Protocol for Sonogashira Cross‐Coupling Reactions of Maleimides. European Journal of Organic Chemistry. 2012(13). 2499–2502. 15 indexed citations
11.
Croix, Cécile, S. Marchand‐Adam, Christine Kellenberger, et al.. (2011). A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate. Biochemical Pharmacology. 83(6). 788–796. 23 indexed citations
12.
Croix, Cécile, David Alagille, Sylvain Normand, et al.. (2010). Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(3). 1019–1022. 38 indexed citations
14.
Viaud‐Massuard, Marie‐Claude, et al.. (2010). Desulfonylation of Indoles and 7-Azaindoles Using Sodium tert-Butoxide. Synlett. 2010(10). 1481–1484. 8 indexed citations
15.
Moreau, Louis, et al.. (2009). Recent advances in development of materials for laser target. Laser and Particle Beams. 27(4). 537–544. 11 indexed citations
16.
Croix, Cécile, et al.. (2008). New Gold-Doped Foams by Copolymerization of Organogold(I) Monomers for Inertial Confinement Fusion (ICF) Targets. Journal of Inorganic and Organometallic Polymers and Materials. 18(3). 334–343. 7 indexed citations
17.
Enguehard‐Gueiffier, Cécile, et al.. (2007). Convenient Synthesis of Alkenyl‐, Alkynyl‐, and Allenyl‐Substituted Imidazo[1,2‐a]pyridines via Palladium‐Catalyzed Cross‐Coupling Reactions. Helvetica Chimica Acta. 90(12). 2349–2367. 19 indexed citations
18.
Croix, Cécile, et al.. (2006). Synthesis of Ketones from Acyl Chlorides and Triorganoindium Reagents by Pd‐Catalyzed Cross‐Coupling. Synthetic Communications. 36(21). 3261–3270. 9 indexed citations
19.
Croix, Cécile, et al.. (2005). Organogold(I) complexes: Synthesis, X-ray crystal structures and aurophilicity. Journal of Organometallic Chemistry. 690(21-22). 4835–4843. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026